The regulation of fetal growth is complex and poorly known. During the first trimester of pregnancy, no strict endocrine mechanisms are involved, but embryonic growth might be controlled at the level of the individual organs by supply of nutrients and by locally active growth factors. Later on, fetal growth depends essentially upon the maternoplacental cooperation in delivering nutrients to the fetus. Therfore, the major role of hormones in fetal growth is to mediate the utilization of available substrate. In late gestation, placental size and fetal growth rate are well correlated, pointing to a key role of the placenta in the regulation of fetal growth. It is therefore important to understand the molecular mechanisms involved in regulating placental development and endocrine functions. TGFα and EGF might play major roles as suggested by the modulation of their receptors with placental development, and by the specific alterations of EGF receptors in intrauterine growth retardation. In addition, human placenta specifically secretes placental growth hormone, the level of which is significantly decreased in the sera of pregnant women bearing a fetus with intrauterine growth retardation.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.